Stock Scorer

Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. reported revenue of 85.4M USD for the quarter ending 30 June 2026, up 4.4% from 81.8M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 85.4M +4.4%
Gross Profit Q2 '26 · ending 30 June 2026 25.7M -25.4%
Operating Income Q2 '26 · ending 30 June 2026 -36.1M —
Net Income Q2 '26 · ending 30 June 2026 -29.5M —
Cost of Revenue Q2 '26 · ending 30 June 2026 59.7M +26.1%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -23.8M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -27.6M —
Shares Outstanding Q2 '26 · ending 30 June 2026 28M -9.2%
EPS Q4 '18 · ending 31 December 2018 -0.31 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 322.7M-91.1M-60.5M-124.2M
20242024-12-31 283.5M-73.9M-42.7M-19.3M
20232023-12-31 289.2M-195.5M-167.8M4.8M
20222022-12-31 619M178.5M143.4M234.7M
20212021-12-31 992.6M676M507.4M514.8M
20202020-12-31 421.7M290.2M214.3M105.5M
20192019-12-31 32.5M-428K-411K4.3M
20182018-12-31 21.4M-5.1M-5.6M-3M
20172017-12-31 18.7M-3.5M-2.5M-1.6M
20162016-12-31 18.3M918K-5.3M617K

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3085.4M
Q1 '262026-03-3171.1M
Q4 '252025-12-3183.3M
Q3 '252025-09-3084.1M
Q2 '252025-06-3081.8M
Q1 '252025-03-3173.5M
Q4 '242024-12-3176.2M
Q3 '242024-09-3071.7M
Q2 '242024-06-3071M
Q1 '242024-03-3164.5M
Q4 '232023-12-3170.5M
Q3 '232023-09-3084.7M
Q2 '232023-06-3067.9M
Q1 '232023-03-3166.2M
Q4 '222022-12-3167.7M
Q3 '222022-09-30105.7M
Q2 '222022-06-30125.3M
Q1 '222022-03-31320.3M
Q4 '212021-12-31251.7M
Q3 '212021-09-30227.9M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3025.7M
Q1 '262026-03-3121.5M
Q4 '252025-12-3132.6M
Q3 '252025-09-3035.5M
Q2 '252025-06-3034.4M
Q1 '252025-03-3128.3M
Q4 '242024-12-3131.8M
Q3 '242024-09-3026.8M
Q2 '242024-06-3026.5M
Q1 '242024-03-3122.1M
Q4 '232023-12-3125.2M
Q3 '232023-09-3039.8M
Q2 '232023-06-3020.6M
Q1 '232023-03-3118.8M
Q4 '222022-12-3113M
Q3 '222022-09-3046.1M
Q2 '222022-06-3065.3M
Q1 '222022-03-31242.5M
Q4 '212021-12-31189.5M
Q3 '212021-09-30184.4M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-36.1M
Q1 '262026-03-31-34.6M
Q4 '252025-12-31-36.2M
Q3 '252025-09-30-15.3M
Q2 '252025-06-30-19.7M
Q1 '252025-03-31-19.8M
Q4 '242024-12-31-16.1M
Q3 '242024-09-30-17.1M
Q2 '242024-06-30-18.9M
Q1 '242024-03-31-21.8M
Q4 '232023-12-31-151.1M
Q3 '232023-09-30214K
Q2 '232023-06-30-19.8M
Q1 '232023-03-31-24.8M
Q4 '222022-12-31-36.6M
Q3 '222022-09-30352K
Q2 '222022-06-3012.8M
Q1 '222022-03-31201.9M
Q4 '212021-12-31150.9M
Q3 '212021-09-30159.3M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-29.5M
Q1 '262026-03-31-24.8M
Q4 '252025-12-31-23.4M
Q3 '252025-09-30-6.6M
Q2 '252025-06-30-19M
Q1 '252025-03-31-11.5M
Q4 '242024-12-31-5.9M
Q3 '242024-09-30-14.6M
Q2 '242024-06-30-8.7M
Q1 '242024-03-31-13.5M
Q4 '232023-12-31-128.1M
Q3 '232023-09-30-13.1M
Q2 '232023-06-30-11.2M
Q1 '232023-03-31-15.3M
Q4 '222022-12-31-23.8M
Q3 '222022-09-301.7M
Q2 '222022-06-3011.5M
Q1 '222022-03-31154M
Q4 '212021-12-31104.3M
Q3 '212021-09-30122.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3059.7M
Q1 '262026-03-3149.6M
Q4 '252025-12-3150.8M
Q3 '252025-09-3048.6M
Q2 '252025-06-3047.4M
Q1 '252025-03-3145.1M
Q4 '242024-12-3144.4M
Q3 '242024-09-3045M
Q2 '242024-06-3044.5M
Q1 '242024-03-3142.4M
Q4 '232023-12-3145.3M
Q3 '232023-09-3044.8M
Q2 '232023-06-3047.3M
Q1 '232023-03-3147.4M
Q4 '222022-12-3154.7M
Q3 '222022-09-3059.6M
Q2 '222022-06-3060.1M
Q1 '222022-03-3177.7M
Q4 '212021-12-3162.1M
Q3 '212021-09-3043.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-23.8M
Q1 '262026-03-317.1M
Q4 '252025-12-31-78.1M
Q3 '252025-09-3011.1M
Q2 '252025-06-30-30.2M
Q1 '252025-03-31-4.4M
Q4 '242024-12-3125M
Q3 '242024-09-30-15.5M
Q2 '242024-06-304.3M
Q1 '242024-03-317.3M
Q4 '232023-12-3114.9M
Q3 '232023-09-3010.2M
Q2 '232023-06-309.7M
Q1 '232023-03-31-7.9M
Q4 '222022-12-3133.2M
Q3 '222022-09-3020.8M
Q2 '222022-06-3011.1M
Q1 '222022-03-31188.4M
Q4 '212021-12-3177.1M
Q3 '212021-09-30152.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-27.6M
Q1 '262026-03-311.9M
Q4 '252025-12-31-83.1M
Q3 '252025-09-305.1M
Q2 '252025-06-30-37M
Q1 '252025-03-31-9.1M
Q4 '242024-12-3121.2M
Q3 '242024-09-30-35M
Q2 '242024-06-30-8.7M
Q1 '242024-03-313.2M
Q4 '232023-12-3111.8M
Q3 '232023-09-305.3M
Q2 '232023-06-30-2.4M
Q1 '232023-03-31-9.9M
Q4 '222022-12-3128.5M
Q3 '222022-09-3015.3M
Q2 '222022-06-307.9M
Q1 '222022-03-31183.1M
Q4 '212021-12-3171.1M
Q3 '212021-09-30148.8M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3028M
Q1 '262026-03-3130.9M
Q3 '252025-09-3030.7M
Q2 '252025-06-3030.5M
Q1 '252025-03-3130.8M
Q3 '242024-09-3030.4M
Q2 '242024-06-3030.1M
Q1 '242024-03-3129.8M
Q3 '232023-09-3030M
Q2 '232023-06-3029.8M
Q1 '232023-03-3129.5M
Q3 '222022-09-3030.9M
Q2 '222022-06-3031.2M
Q1 '222022-03-3131.2M
Q3 '212021-09-3031.2M
Q2 '212021-06-3030.8M
Q1 '212021-03-3130.8M
Q3 '202020-09-3023.5M
Q2 '202020-06-3022.9M
Q1 '202020-03-3121.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q4 '182018-12-31-0.31
Q3 '182018-09-30-0.29
Q2 '182018-06-30-0.32
Q1 '182018-03-31-0.26
Q4 '172017-12-31-0.14
Q3 '172017-09-300.00